Day

May 8, 2019

8
May
2019

An Elephant for Immunology Drugs: Sheila Gujrathi on The Long Run

Today’s guest on The Long Run is Sheila Gujrathi. Sheila is the CEO of San Diego-based Gossamer Bio. This immunology drug developer is an example of what I’ve lately started calling an “elephant” startup (see February TR coverage of Maze Therapeutics for another example). Gossamer was co-founded by Sheila and Faheem Hasnain. They were the dynamic duo that led Receptos...
Read More